Hippo Signaling: Advances in Potential Therapeutic Targets for Sinoatrial Node Disorders

TL;DR

This paper reviews how the Hippo signaling pathway helps maintain the heart's natural pacemaker and could lead to new treatments for heart rhythm disorders.

Contribution

The paper highlights recent discoveries on Hippo signaling's role in sinoatrial node homeostasis and identifies potential therapeutic targets.

Findings

Hippo signaling is critical for maintaining sinoatrial node homeostasis.

The pathway offers potential therapeutic targets for sinoatrial node disorders.

Recent molecular findings reveal Hippo's role in cardiac pacemaker regulation.

Abstract

The cardiac conduction system (CCS) propagates electrical impulses, generates cardiac contractions, and ultimately ensures regular heartbeats. Disruptions within the CCS lead to cardiac arrhythmias, which are known to be the leading cause of cardiac-related mortalities in humans. The sinoatrial node (SAN) is a key component of the CCS and functions as the natural cardiac pacemaker to initiate normal cardiac impulse and conduction. The SAN is characterized by significant heterogeneity and contains various cell types, including pacemaker cells that spontaneously generate action potentials to maintain a constant beating rhythm. The fundamental Hippo signaling pathway plays a key role in heart development and regeneration. Recently, the Hippo signaling pathway is indicated as a critical pathway for maintaining SAN homeostasis, suggesting therapeutic targets for SAN disorders. This mini-review focuses on the recent molecular and mechanistic findings of Hippo’s involvement in regulating SAN homeostasis and discusses potential new therapeutic targets for SAN pathologies.

Figures